First Time Loading...

Medpace Holdings Inc
NASDAQ:MEDP

Watchlist Manager
Medpace Holdings Inc Logo
Medpace Holdings Inc
NASDAQ:MEDP
Watchlist
Price: 398.52 USD 2.38% Market Closed
Updated: May 15, 2024
Section:
 

Relative Value

The Relative Value of one MEDP stock under the Base Case scenario is 392.44 USD. Compared to the current market price of 398.52 USD, Medpace Holdings Inc is Overvalued by 2%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MEDP Relative Value
Base Case
392.44 USD
Overvaluation 2%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6.3
P/S
P/S
Price to Sales
6.3
vs History
15
vs Industry
30
Median 3Y
4.8
Median 5Y
4.6
Industry
4
Forward
5.5
More Details
39.4
P/E
P/E
Price to Earnings
39.4
vs History
11
vs Industry
15
Median 3Y
30.4
Median 5Y
30.9
Industry
31.1
Forward
36.7
More Details
24.3
P/OCF
P/OCF
Price to OCF
24.3
vs History
6
vs Industry
27
Median 3Y
20.7
Median 5Y
18.9
Industry
23.7
More Details
34.4
P/FCFE
P/FCFE
Price to FCFE
34.4
vs History
17
vs Industry
21
Median 3Y
25.8
Median 5Y
25.6
Industry
28.7
More Details
18.3
P/B
P/B
Price to Book Value
18.3
vs History
9
vs Industry
1
Median 3Y
16.2
Median 5Y
7.5
Industry
2.6
More Details
6.1
EV/S
EV/S
Enterprise Value to Sales
6.1
vs History
9
vs Industry
29
Median 3Y
4.9
Median 5Y
4.4
Industry
3.9
Forward
5.3
More Details
21.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
21.7
vs History
6
vs Industry
16
Median 3Y
16.8
Median 5Y
15.2
Industry
8
More Details
31.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
31.2
vs History
6
vs Industry
12
Median 3Y
24.3
Median 5Y
22.7
Industry
17.5
Forward
28
More Details
33.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
33.6
vs History
7
vs Industry
14
Median 3Y
26.2
Median 5Y
25.1
Industry
22.8
Forward
30.2
More Details
23.5
EV/OCF
EV/OCF
Enterprise Value to OCF
23.5
vs History
6
vs Industry
29
Median 3Y
20.5
Median 5Y
18.4
Industry
21.9
More Details
25.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
25.2
vs History
6
vs Industry
28
Median 3Y
22.4
Median 5Y
20.7
Industry
27.9
More Details
8.7
EV/IC
EV/IC
Enterprise Value to IC
8.7
vs History
1
vs Industry
10
Median 3Y
5.4
Median 5Y
4.5
Industry
2.4
More Details

Multiples Across Competitors

MEDP Competitors Multiples
Medpace Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Medpace Holdings Inc
NASDAQ:MEDP
12.3B USD 6.3 39.4 31.2 33.6
US
Thermo Fisher Scientific Inc
NYSE:TMO
230B USD 5.4 38.4 23.6 34.6
US
Danaher Corp
NYSE:DHR
192B USD 4.4 23.8 17.3 21.3
US
Agilent Technologies Inc
NYSE:A
44.3B USD 6.6 35.9 28.6 34.4
US
IQVIA Holdings Inc
NYSE:IQV
42B USD 2.8 30.9 16.8 25.9
KR
Samsung Biologics Co Ltd
KRX:207940
55.6T KRW 15 64.8 34.2 49.2
CH
Lonza Group AG
SIX:LONN
36.6B CHF 5.4 56 19.2 28.2
US
Mettler-Toledo International Inc
NYSE:MTD
32B USD 8.4 41.1 28 31.2
IE
ICON PLC
NASDAQ:ICLR
26.1B USD 3.2 38.2 17.2 26.5
US
West Pharmaceutical Services Inc
NYSE:WST
25.9B USD 8.8 45.5 31.6 38.3
US
Waters Corp
NYSE:WAT
21.3B USD 7.3 35.3 23.6 29.2

See Also

Summary
MEDP intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDP stock valuation using valuation multiples.
Wall Street Estimates
MEDP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.